{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:40:46Z","timestamp":1791819646968,"version":"4.3.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Normothermic regional perfusion (NRP) has shown superior outcomes in donation after circulatory death, with a low incidence of biliary complications. Not all NRP parameters are unequivocal in supporting transplantation, and further assessment may be required using ex situ normothermic machine perfusion (NMP). Theater and recipient factors may also require extended preservation using NMP. The present study reports our experience with sequential NRP-NMP livers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Single-center retrospective analysis of livers undergoing both NRP and NMP, divided into cohorts based on indication for NMP: D-NRP-NMP for donor indications and R-NRP-NMP where the indication was recipient\/logistical reason.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>There were 70 NRP-NMP assessments between May 2017 and August 2024. Sixty-five percent (24\/37) of D-NRP-NMP livers and 85% (28\/33) of R-NRP-NMP livers were transplanted. Two-thirds of the livers (19\/30) failing NRP lactate criteria in the D-NRP-NMP group were transplanted after favorable NMP. Similarly, 60% (9\/15) of livers failing NRP alanine transaminase (ALT) cutoff criteria, including 3 livers with ALT &gt;1000 U\/L, were successfully transplanted. Collectively, 11 livers (30%) failed both lactate and ALT criteria, with NRP-NMP able to recover 7 (64%) of these livers for transplant. Overall, outcomes of NRP-NMP were satisfactory with 2% primary nonfunction, 23% Olthoff early allograft dysfunction, 56% Kidney Disease Improving Global Outcome acute kidney injury stage \u22652, and 6% nonanastomotic stricture, none requiring biliary intervention. There was no difference in transplant outcomes between the 2 groups, with similar 1- and 3-y patient and graft survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>NRP and NMP are complementary, with further NMP assessment able to use liver grafts with marginal NRP parameters or facilitating increased preservation time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005659","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:00:36Z","timestamp":1772200836000},"page":"e1424-e1436","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Sequential In Situ Normothermic Regional Perfusion and Ex Situ Normothermic Machine Perfusion in Controlled Donation After Circulatory Death Liver Transplantation: A Retrospective Single-center Experience"],"prefix":"10.1097","volume":"110","author":[{"given":"Rohit","family":"Gaurav","sequence":"first","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Paul","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Swift","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Martin","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Philipoff","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Webster","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Spiers","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Richards","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwilym","family":"Webb","sequence":"additional","affiliation":[{"name":"Cambridge Liver Unit, Cambridge NIHR Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Allison","sequence":"additional","affiliation":[{"name":"Cambridge Liver Unit, Cambridge NIHR Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Watson","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."},{"name":"Department of Surgery, University of Cambridge, Cambridge, United Kingdom."},{"name":"National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge, United Kingdom."},{"name":"NIHR Blood and Transplant Research Unit (BTRU) at the University of Cambridge in Collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT), Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Butler","sequence":"additional","affiliation":[{"name":"Roy Calne Transplant Unit, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom."},{"name":"Department of Surgery, University of Cambridge, Cambridge, United Kingdom."},{"name":"National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"R1-20260616","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation.","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"R2-20260616","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation\u2014a randomized trial.","volume":"384","author":"van Rijn","year":"2021","journal-title":"N Engl J Med"},{"key":"R3-20260616","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/ajt.15241","article-title":"In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival.","volume":"19","author":"Watson","year":"2019","journal-title":"Am J Transplant"},{"key":"R4-20260616","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/ajt.16899","article-title":"Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss.","volume":"22","author":"Hessheimer","year":"2022","journal-title":"Am J Transplant"},{"key":"R5-20260616","doi-asserted-by":"crossref","first-page":"e003287","DOI":"10.1136\/bmjopen-2013-003287","article-title":"Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study.","volume":"3","author":"Callaghan","year":"2013","journal-title":"BMJ Open"},{"key":"R6-20260616","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2018.12.033","article-title":"Survival advantage for patients accepting the offer of a circulatory death liver transplant.","volume":"70","author":"Taylor","year":"2019","journal-title":"J Hepatol"},{"key":"R7-20260616","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/bjs\/znab347","article-title":"National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors.","volume":"109","author":"Wallace","year":"2022","journal-title":"Br J Surg"},{"key":"R8-20260616","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2023.01.025","article-title":"Utilization of livers donated after circulatory death for transplantation\u2014an international comparison.","volume":"78","author":"Eden","year":"2023","journal-title":"J Hepatol"},{"key":"R10-20260616","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/ajt.14687","article-title":"Observations on the ex situ perfusion of livers for transplantation.","volume":"18","author":"Watson","year":"2018","journal-title":"Am J Transplant"},{"key":"R11-20260616","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial.","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surg"},{"key":"R12-20260616","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1097\/SLA.0000000000005934","article-title":"Normothermic machine perfusion of donor livers for transplantation in the United States\u2014a randomized controlled trial.","volume":"278","author":"Chapman","year":"2023","journal-title":"Ann Surg"},{"key":"R13-20260616","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/ajt.12927","article-title":"In situ normothermic regional perfusion for controlled donation after circulatory death\u2014the United Kingdom experience.","volume":"14","author":"Oniscu","year":"2014","journal-title":"Am J Transplant"},{"key":"R14-20260616","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.healun.2020.10.001","article-title":"A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors.","volume":"39","author":"Messer","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R15-20260616","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/SLA.0000000000005428","article-title":"Liver transplantation outcomes from controlled circulatory death donors: SCS vs in situ NRP vs ex situ NMP.","volume":"275","author":"Gaurav","year":"2022","journal-title":"Ann Surg"},{"key":"R16-20260616","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-20260616","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/TP.0000000000001576","article-title":"Factors associated with short- and long-term liver graft survival in the United Kingdom: development of a UK donor liver index.","volume":"101","author":"Collett","year":"2017","journal-title":"Transplantation"},{"key":"R18-20260616","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2017.10.034","article-title":"The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation.","volume":"68","author":"Schlegel","year":"2018","journal-title":"J Hepatol"},{"key":"R19-20260616","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"R20-20260616","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TP.0b013e318225db4d","article-title":"Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score.","volume":"92","author":"Barber","year":"2011","journal-title":"Transplantation"},{"key":"R21-20260616","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22091","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"key":"R22-20260616","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/lt.23990","article-title":"A score model for the continuous grading of early allograft dysfunction severity.","volume":"21","author":"Pareja","year":"2015","journal-title":"Liver Transpl"},{"key":"R24-20260616","year":"2012","journal-title":"NHS Blood and Transplant. Version 2.6"},{"key":"R25-20260616","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/TP.0000000000000082","article-title":"Normothermic regional perfusion for donation after circulatory death without prior heparinization.","volume":"97","author":"Butler","year":"2014","journal-title":"Transplantation"},{"key":"R26-20260616","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/15269248221087430","article-title":"The 6 C\u2019s of normothermic regional perfusion.","volume":"32","author":"Richards","year":"2022","journal-title":"Prog Transplant"},{"key":"R27-20260616","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/ajt.15775","article-title":"Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: a United Kingdom and Canadian proposal.","volume":"20","author":"Manara","year":"2020","journal-title":"Am J Transplant"},{"key":"R28-20260616","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s40472-018-0178-9","article-title":"From \u201cGut Feeling\u201d to objectivity: machine preservation of the liver as a tool to assess organ viability.","volume":"5","author":"Watson","year":"2018","journal-title":"Curr Transplant Rep"},{"key":"R29-20260616","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/TP.0000000000004263","article-title":"Predicting early allograft function after normothermic machine perfusion.","volume":"106","author":"Watson","year":"2022","journal-title":"Transplantation"},{"key":"R30-20260616","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/TXD.0000000000000611","article-title":"Normothermic machine perfusion of deceased donor liver grafts is associated with improved postreperfusion hemodynamics.","volume":"2","author":"Angelico","year":"2016","journal-title":"Transplant Direct"},{"key":"R31-20260616","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajt.2025.01.007","article-title":"Normothermic regional and ex situ perfusion reduces postreperfusion syndrome in donation after circulatory death liver transplantation: a retrospective comparative study.","volume":"25","author":"Puttappa","year":"2025","journal-title":"Am J Transplant"},{"key":"R32-20260616","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2011.03834.x","article-title":"Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation.","volume":"12","author":"Fondevila","year":"2012","journal-title":"Am J Transplant"},{"key":"R33-20260616","doi-asserted-by":"crossref","first-page":"e14134","DOI":"10.1111\/ctr.14134","article-title":"Incidence and risk factors of primary non\u2010function after liver transplantation using grafts from uncontrolled donors after circulatory death.","volume":"35","author":"Justo","year":"2021","journal-title":"Clin Transplant"},{"key":"R34-20260616","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/lt.26512","article-title":"Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: a systematic review.","volume":"28","author":"Schurink","year":"2022","journal-title":"Liver Transpl"},{"key":"R35-20260616","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory.","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab"},{"key":"R36-20260616","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.transproceed.2021.05.013","article-title":"Clinical Utility and evolution of donor serum lactate during normothermic regional perfusion in uncontrolled donation after circulatory death.","volume":"53","author":"Rodr\u00edguez-Villar","year":"2021","journal-title":"Transplant Proc"},{"key":"R37-20260616","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/SLA.0b013e31822b8b2f","article-title":"Superior preservation of DCD livers with continuous normothermic perfusion.","volume":"254","author":"Fondevila","year":"2011","journal-title":"Ann Surg"},{"key":"R38-20260616","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.24666","article-title":"Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion.","volume":"23","author":"De Carlis","year":"2017","journal-title":"Liver Transpl"},{"key":"R39-20260616","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/TP.0000000000003595","article-title":"How to preserve liver grafts from circulatory death with long warm ischemia? A retrospective Italian cohort study with normothermic regional perfusion and hypothermic oxygenated perfusion.","volume":"105","author":"De Carlis","year":"2021","journal-title":"Transplantation"},{"key":"R40-20260616","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/lt.25899","article-title":"Sequential use of normothermic regional and ex situ machine perfusion in donation after circulatory death liver transplant.","volume":"27","author":"Ghinolfi","year":"2021","journal-title":"Liver Transpl"},{"key":"R41-20260616","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/TP.0000000000005301","article-title":"Outcomes of DCD liver transplant using sequential normothermic regional perfusion and normothermic machine perfusion or NRP alone versus static cold storage.","volume":"109","author":"Croome","year":"2025","journal-title":"Transplantation"},{"key":"R42-20260616","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/ajt.17037","article-title":"Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: a European observational cohort study.","volume":"22","author":"Br\u00fcggenwirth","year":"2022","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:00:54Z","timestamp":1781647254000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005659","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}